Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma ; day:9 ; month:12 ; year:2020 ; pages:1-14
Investigational new drugs ; (9.12.2020), 1-14
- Creator
-
Dell’Anno, Irene
Martin, Sarah A.
Barbarino, Marcella
Melani, Alessandra
Silvestri, Roberto
Bottaro, Maria
Paolicchi, Elisa
Corrado, Alda
Cipollini, Monica
Melaiu, Ombretta
Giordano, Antonio
Luzzi, Luca
Gemignani, Federica
Landi, Stefano
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-020-01040-y
- URN
-
urn:nbn:de:101:1-2021011715563749488147
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dell’Anno, Irene
- Martin, Sarah A.
- Barbarino, Marcella
- Melani, Alessandra
- Silvestri, Roberto
- Bottaro, Maria
- Paolicchi, Elisa
- Corrado, Alda
- Cipollini, Monica
- Melaiu, Ombretta
- Giordano, Antonio
- Luzzi, Luca
- Gemignani, Federica
- Landi, Stefano
- SpringerLink (Online service)
Other Objects (12)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Physician requests by patients with malignant pleural mesothelioma in Japan
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Physician requests by patients with malignant pleural mesothelioma in Japan
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Physician requests by patients with malignant pleural mesothelioma in Japan